• TECHNOLOGY
    • Peripheral Solutions
      • Impede
      • Impede-FX
      • Impede-FX RAPIDFILL
      • Trellix
    • Neurovascular Solutions
      • Trellix
    • Aortic Solutions
  • EVIDENCE
  • COMPANY
    • About the Company
    • Distributors
    • Careers
    • Compliance
    • Patents
  • NEWS & EVENTS
CONTACT
Shape Memory Medical Shape Memory Medical
  • TECHNOLOGY
    • Technology
      • Peripheral Solutions
        • Impede
        • Impede-FX
        • Impede-FX RAPIDFILL
        • Trellix
      • Neurovascular Solutions
        • Trellix
      • Aortic Solutions
  • EVIDENCE
    • Publications
    • Presentations & Webinars
    • Clinical Trials
    • Case Studies
  • Company
    • COMPANY
      • Distributors
      • Careers
      • Compliance
      • Patents
  • News & Events
CONTACT
Shape Memory Medical

News & Events

NEWS
EVENTS

Press Releases

Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral vascular and neurovascular markets, announced the first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the Company’s prospective, multicenter, registry study of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization.
Shape Memory Medical Announces First Patient Treated in the EMBO-Post Market Surveillance Registry in Germany
https://www.businesswire.com/news/home/20230222005206/en/Shape-Memory-Medical-Announces-First-Patient-Treated-in-the-EMBO-Post-Market-Surveillance-Registry-in-Germany

Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral vascular and neurovascular markets, announced the first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the Company’s prospective, multicenter, registry study of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization.

https://www.businesswire.com/news/home/20230222005206/en/Shape-Memory-Medical-Announces-First-Patient-Treated-in-the-EMBO-Post-Market-Surveillance-Registry-in-Germany
Read The Full Announcement
Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral vascular and neurovascular markets, announced preliminary six-month results from the AAA-SHAPE Safety Trial. Data will be presented during the 49th Annual VEITH Symposium in New York City on Tuesday, November 15, 2022.
Preliminary Data from AAA-SHAPE to be Presented at VEITH 2022
https://www.businesswire.com/news/home/20221114005115/en/Preliminary-Data-from-AAA-SHAPE-to-be-Presented-at-VEITH-2022

Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral vascular and neurovascular markets, announced preliminary six-month results from the AAA-SHAPE Safety Trial. Data will be presented during the 49th Annual VEITH Symposium in New York City on Tuesday, November 15, 2022.

https://www.businesswire.com/news/home/20221114005115/en/Preliminary-Data-from-AAA-SHAPE-to-be-Presented-at-VEITH-2022
Read The Full Announcement
Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral and neurovascular markets, announced the completion of patient enrollment in AAA-SHAPE, the Company’s prospective, multicenter early feasibility safety study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR).
Shape Memory Medical Completes Enrollment in the AAA-SHAPE Early Feasibility Study
https://www.businesswire.com/news/home/20220829005133/en/Shape-Memory-Medical-Completes-Enrollment-in-the-AAA-SHAPE-Early-Feasibility-Study

Shape Memory Medical Inc., developer of custom, proprietary shape memory polymers for the peripheral and neurovascular markets, announced the completion of patient enrollment in AAA-SHAPE, the Company’s prospective, multicenter early feasibility safety study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR).

https://www.businesswire.com/news/home/20220829005133/en/Shape-Memory-Medical-Completes-Enrollment-in-the-AAA-SHAPE-Early-Feasibility-Study
Read The Full Announcement
Shape Memory Medical Inc., developer of shape memory polymer devices for peripheral and neurovascular markets, announced today that its 1,500th patient has been treated, marking a significant milestone for the Company’s portfolio of shape memory polymer embolotherapy devices – The IMPEDE® Embolization Plug Family and the TrelliX® Embolic Coil.
Shape Memory Medical Celebrates Treatment of 1,500th Patient
https://www.businesswire.com/news/home/20220803005181/en/Shape-Memory-Medical-Celebrates-Treatment-of-1500th-Patient

Shape Memory Medical Inc., developer of shape memory polymer devices for peripheral and neurovascular markets, announced today that its 1,500th patient has been treated, marking a significant milestone for the Company’s portfolio of shape memory polymer embolotherapy devices – The IMPEDE® Embolization Plug Family and the TrelliX® Embolic Coil.

https://www.businesswire.com/news/home/20220803005181/en/Shape-Memory-Medical-Celebrates-Treatment-of-1500th-Patient
Read The Full Announcement
Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company’s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR).
Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study
https://www.businesswire.com/news/home/20210824005571/en

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company’s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR).

https://www.businesswire.com/news/home/20210824005571/en
Read The Full Announcement
Shape Memory Medical Names Anthony Lipp as Chief Commercial Officer
https://www.businesswire.com/news/home/20210429005109/en/Shape-Memory-Medical-Names-Anthony-Lipp-as-Chief-Commercial-Officer

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Anthony Lipp as Chief Commercial Officer. Anthony will be responsible for driving the development and implementation of global sales strategies of its shape memory polymer embolization products and therapies.

https://www.businesswire.com/news/home/20210429005109/en/Shape-Memory-Medical-Names-Anthony-Lipp-as-Chief-Commercial-Officer
Read The Full Announcement
Shape Memory Medical Inc. announced that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE®-FX Embolization Plug in Japan.
Shape Memory Medical Receives PMDA Approval for the IMPEDE-FX Embolization Plug
https://www.businesswire.com/news/home/20210323005174/en/Shape-Memory-Medical-Receives-PMDA-Approval-for-the-IMPEDE-FX-Embolization-Plug

Shape Memory Medical Inc. announced that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE®-FX Embolization Plug in Japan.

https://www.businesswire.com/news/home/20210323005174/en/Shape-Memory-Medical-Receives-PMDA-Approval-for-the-IMPEDE-FX-Embolization-Plug
Read The Full Announcement
Shape Memory Medical Receives CE Mark for IMPEDE-FX RapidFill
https://www.businesswire.com/news/home/20210310005093/en/Shape-Memory-Medical-Receives-CE-Mark-for-IMPEDE-FX-RapidFill

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced CE Mark Approval for the IMPEDE-FX RapidFill Device, an expansion of the IMPEDE family of biodegradable peripheral vascular embolization plugs.

https://www.businesswire.com/news/home/20210310005093/en/Shape-Memory-Medical-Receives-CE-Mark-for-IMPEDE-FX-RapidFill
Read The Full Announcement
Shape Memory Medical Names Mary Dennehy as Vice President of Marketing
https://www.businesswire.com/news/home/20200925005059/en/Shape-Memory-Medical-Names-Mary-Dennehy-as-Vice-President-of-Marketing

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing. Mary will be responsible for driving the development and implementation of global marketing strategies and initiatives that support commercialization of its Shape Memory Polymer embolization products and therapies.

https://www.businesswire.com/news/home/20200925005059/en/Shape-Memory-Medical-Names-Mary-Dennehy-as-Vice-President-of-Marketing
Read The Full Announcement
Shape Memory Medical Announces First Patient Enrollment in AAA-SHAPE Study
https://www.businesswire.com/news/home/20200916005240/en/Shape-Memory-Medical-Announces-Patient-Enrollment-AAA-SHAPE

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE, the Company’s prospective safety study of the IMPEDE-FX Embolization Plug devices when used for abdominal aortic aneurysm (AAA) sac filling during elective endovascular aneurysm repair (EVAR). The study’s first procedure was performed by Andrew Holden, MBChB, an interventional radiologist and Andrew Hill, MBChB, a vascular surgeon at Auckland City Hospital in Auckland, New Zealand.

https://www.businesswire.com/news/home/20200916005240/en/Shape-Memory-Medical-Announces-Patient-Enrollment-AAA-SHAPE
Read The Full Announcement
Shape Memory Medical Receives PMDA Approval for the IMPEDE Embolization Plug Family
https://www.businesswire.com/news/home/20191202005112/en/Shape-Memory-Medical-Receives-PMDA-Approval-IMPEDE%C2%AE

Shape Memory Medical Inc. announced today that its IMPEDE Embolization Plugs have been approved in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA). Cosmotec, which is a Group Company of M3 Inc https://corporate.m3.com/en/ listed on the Tokyo Stock Exchange (TYO:2413), championed the approval process in Japan and is Shape Memory Medical’s distribution partner for all of its peripheral embolization products. The IMPEDE Embolization Plug is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. It is available in three sizes, to treat vessels up to 10 mm in diameter. IMPEDE Embolization Plugs feature proprietary shape memory polymer (SMP) technology.

https://www.businesswire.com/news/home/20191202005112/en/Shape-Memory-Medical-Receives-PMDA-Approval-IMPEDE%C2%AE
Read The Full Announcement
Shape Memory Medical Wins 2019 R&D 100 Award for Its Novel IMPEDE Embolization Device
https://www.businesswire.com/news/home/20191104005896/en/Shape-Memory-Medical-Wins-2019-100-Award

Shape Memory Medical is delighted to announce that the IMPEDE Embolization Plug, a member of its innovative line of vascular embolization products, has won one of the 2019 R&D 100 Awards (https://www.rd100conference.com/). These awards recognize the most promising new products, processes, materials, and software developed throughout the world and introduced to the market the previous year.

https://www.businesswire.com/news/home/20191104005896/en/Shape-Memory-Medical-Wins-2019-100-Award
Read The Full Announcement
Shape Memory Medical Receives CE mark for the TrelliX Embolic Coil System
https://www.businesswire.com/news/home/20191020005036/en/Shape-Memory-Medical-Receives-CE-Mark-TrelliX%C2%AE

Shape Memory Medical Inc. announced today it has received CE mark for its TrelliX Embolic Coil System. The TrelliX Embolic Coil System is intended to obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. Indications include: Intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, arterial and venous embolizations in the peripheral vasculature. The TrelliX Embolic Coil System features proprietary shape memory polymer (SMP) technology.

https://www.businesswire.com/news/home/20191020005036/en/Shape-Memory-Medical-Receives-CE-Mark-TrelliX%C2%AE
Read The Full Announcement
Shape Memory Medical Receives FDA Clearance for the IMPEDE-FX Embolization Plug
https://www.businesswire.com/news/home/20190528005080/en/Shape-Memory-Medical-Receives-FDA-Clearance-IMPEDE%C2%AE

Shape Memory Medical Inc. announced today it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the IMPEDE-FX Embolization Plug. The IMPEDE-FX Embolization Plug is an adjunct to the IMPEDE Embolization Plug which previously received 510(k) clearance by the FDA and is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The IMPEDE-FX is available in three sizes, with the maximum device having an expanded diameter of 12 mm.

https://www.businesswire.com/news/home/20190528005080/en/Shape-Memory-Medical-Receives-FDA-Clearance-IMPEDE%C2%AE
Read The Full Announcement
Shape Memory Medical Receives FDA Clearance for the IMPEDE Embolization Plug
https://www.businesswire.com/news/home/20180626005492/en/Shape-Memory-Medical-Receives-FDA-Clearance-IMPEDE%C2%AE

Shape Memory Medical Inc. announced today it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the IMPEDE Embolization Plug. The IMPEDE Embolization Plug is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. It is available in three sizes, to treat vessels up to 10 mm in diameter.

https://www.businesswire.com/news/home/20180626005492/en/Shape-Memory-Medical-Receives-FDA-Clearance-IMPEDE%C2%AE
Read The Full Announcement
Shape Memory Medical Raises Series B, Led by HBM Healthcare Investments Ltd.
https://www.businesswire.com/news/home/20170725005541/en/Shape-Memory-Medical-Raises-Series-Led-HBM

Shape Memory Medical Inc. announced today the initial closing of its Series-B Preferred Stock financing. The round was led by HBM Healthcare Investments Ltd. Current investors, including affiliates of Wexford Capital LP and HBM-MedFocus Funds participated in this financing, and were joined by new investor Emergent Medical Partners.

https://www.businesswire.com/news/home/20170725005541/en/Shape-Memory-Medical-Raises-Series-Led-HBM
Read The Full Announcement
Shape Memory Medical Hires Industry Veteran Ted Ruppel as CEO
https://www.prnewswire.com/news-releases/shape-memory-therapeutics-hires-industry-veteran-ted-ruppel-as-ceo-300167226.html

Shape Memory Medical (formerly Shape Memory Therapeutics (SMT)) announced today the hiring of medical device industry veteran Ted Ruppel as President & CEO.

https://www.prnewswire.com/news-releases/shape-memory-therapeutics-hires-industry-veteran-ted-ruppel-as-ceo-300167226.html
Read The Full Announcement
Load more

Upcoming Events

Critical Issues America 2023

February 10-11, 2023
The Biltmore Hotel
Coral Gables, Florida

Visit us at our booth!

TED (Transformative Endovascular Decisions) 2023

March 19-21, 2023
The Phoenician
Scottsdale, Arizona

Visit us at our booth!

Charing Cross Symposium

April 25-27, 2023
Hilton London Metropole
London, United Kingdom

Visit us at our booth!

Women’s Vascular Summit

April 28-29, 2023
The University of Buffalo, Jacobs School of Medicine
Buffalo, New York

Visit us at our booth!

Shape Memory Medical logo white
Follow us

Careers
Complaints
Compliance
Distributors
Patents
Patient Information
Portal
Privacy

Address
807 Aldo Avenue, Suite 109
Santa Clara, CA 95054

Telephone & Contact
+1 408 649 5175
info@shapemem.com

©2023 Shape Memory Medical
All Rights Reserved
LIT1099 Rev C

Cookies To make this site work properly, we sometimes place small data files called cookies on your device. To continue using this web site, click the Accept button or the Change Settings button for more options.
Accept
Change Settings
Cookie Box Settings
Cookie Box Settings

Privacy settings

Decide which cookies you want to allow. You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function. Learn more about the cookies we use.

With the slider, you can enable or disable different types of cookies:

  • Block all
  • Essential
  • Functionality
  • Analytics
  • Advertising

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected

This website won't:

  • Remember your login details
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country

This website won't:

  • Remember your login details
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions

This website won't:

  • Remember your login details
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sites
  • Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sitesl Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website won't:

  • Remember your login details
Save & Close